Pharmaceuticals
-
Key human challenge expert Adrian Wildfire rejoins hVIVO for Open Orphan boost (ORPH)
-
Open Orphan’s hVIVO expands lab growth revenue with three new contract wins (ORPH)
-
The science that makes the Psychedelic Boom inevitable and how to position yourself ahead of it – Numinus Wellness Inc. (TSX-V:NUMI)
-
Open Orphan hits accumulation stage with operational profitability slated for Q3 2020 (ORPH)
-
XPhyto (CSE:XPHY│OTC:XPHYF) – an exhilarating biotech company with Big Pharma potential!
-
300 million people suffer with the extreme burden of depression, and one company has the answer - Champignon Brands (CSE:SHRM│OTC:SHRMF)
-
VIDEO: Open Orphan’s Cathal Friel on firm’s ambitious plans in the coronavirus vaccination space
-
Open Orphan races ahead with £3.5m US human challenge study contract (ORPH)
-
Open Orphan kickstarts Covid-19 test (ORPH)
-
Omega Diagnostics ramps up Covid-19 antibody tests to 1 million a month, could fly higher (ODX)
-
First profits and underlying business growth make YourGene a buy (YGEN)
-
Coronavirus test maker Novacyt rockets 900% but investors get sinking feeling (NCYT)
-
VIDEO: Open Orphan’s Cathal Friel details ambitious 2020 plans following £5.3m raise in exclusive presentation (ORPH)
-
Open Orphan expects profits within months as it plans role in coronavirus treatment (ORPH)
Open Orphan’s (LSE:ORPH) exec chair has said he “could not have been happier” with the pharma firm’s recent £5.3 million placing, claiming the...
-
Cathal Friel hails “once in a lifetime” opportunity as Open Orphan/hVIVO merger passes (ORPH)
